Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D001007:Anxiety / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D006980:Hyperthyroidism / Q000188:drug therapy*; D008881:Migraine Disorders / Q000517:prevention & control; D009203:Myocardial Infarction / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists